COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 73: Articles 721-730  | Next

Magnitude of Potential Biases in COVID-19 Vaccine Effectiveness Studies due to Differential Healthcare seeking following Home Testing: Implications for Test Negative Design Studies
Qasmieh, S. A., Ferdinands, J. M., Chung, J. R., Wiegand, R. E., Flannery, B. M., Rane, M. S., Nash, D.
10.1101/2024.12.30.24319700 — Posted: 2024-12-31
An infection prediction model developed from inpatient data can predict out-of-hospital COVID-19 infections from wearable data when controlled for dataset shift
Feng, T., Mariani, S., Conroy, B., Damiano, R., Silva, I., Swearingen, D., McFarlane, D. C.
10.1101/2024.12.31.24319816 — Posted: 2024-12-31
Effectiveness of COVID-19 vaccines against SARS-CoV-2 infection and symptomatic infection in the England Winter Coronavirus (COVID-19) Infection Study cohort
Abdul Aziz, N., Andrews, N., Rawlinson, C., Buckley, A., Allen, A.
10.1101/2024.12.30.24319550 — Posted: 2024-12-31
Sociodemographic characteristics of SARS-CoV-2 serosurveillance studies with diverse recruitment strategies, Canada, 2020 to 2023
Knight, M. J., Yu, Y., Chen, J., O'Brien, S. F., Buckeridge, D. L., Charlton, C., Russell, W. A.
10.1101/2024.12.30.24319767 — Posted: 2024-12-31
Investigating the Impact of Remote Learning on Undergraduate Students Academic Success and Mental Health during the COVID-19 Lockdown
Nano, J. P., Catterall, W. A., Chang, M. L., Ghaly, M. H.
10.1101/2024.12.30.24319774 — Posted: 2024-12-31
Autoantibodies to Arginine-rich Sequences Mimicking Epstein-Barr Virus in Post-COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
Hoheisel, F., Fleischer, K. M., Rubarth, K., Sepulveda, N., Bauer, S., Konietschke, F., Kedor, C., Stein, A. E., Wittke, K., Seifert, M., Bellmann-Strobl, J., Mautner, J., Behrends, U., Scheibenbogen, C., Sotzny, F.
10.1101/2024.12.30.24319800 — Posted: 2024-12-31
The association between routine immunisation and COVID-19 vaccination in small island developing states
Patel, C., Bilgin, G., Hayen, A., Kirk, M., Ali, A., Dey, A., Sargent, G., Sheel, M.
10.1101/2024.12.28.24319741 — Posted: 2024-12-30
Enhanced RNA replication and pathogenesis in recent SARS-CoV-2 variants harboring the L260F mutation in NSP6
Taha, T. Y., Ezzatpour, S., Hayashi, J. M., Ye, C., Zapatero-Belinchon, F. J., Rosecrans, J. A., Kimmerly, G. R., Chen, I. P., Walcott, K., Kurianowicz, A., Jorgens, D. M., Chaplin, N. R., Choi, A., Buchholz, D. W., Sahler, J., Hilt, Z. T., Imbiakha, B., Vagi-Szmola, C., Montano, M., Stevenson, E., Gordon, M., Swaney, D. L., Krogan, N. J., Martinez-Sobrido, L., Aguilar, H. C., Ott, M.
10.1101/2024.12.30.628795 — Posted: 2024-12-30
LC-MS/MS characterization of SOBERANA(R)02, a receptor binding domain-tetanus toxoid conjugate vaccine against SARS-CoV-2
Martinez, O., Santana-Medero, D., Pousa, S., Soubal, J. P., Rodriguez-Ulloa, A., Ramos-Bermudez, P. E., Besada, V., Garrido, R., Carvalho, P., Batista, M., Zetl, K., Wisniewski, J., Boggiano, T., Valdes-Balbin, Y., Garcia-Rivera, D., G. Rivera, D., Verez Bencomo, V., Gonzalez, L. J.
10.1101/2024.12.27.630511 — Posted: 2024-12-30
Hydrogen sulfide (H2S) coordinates redox balance, carbon metabolism, and mitochondrial bioenergetics to suppress SARS-CoV-2 infection.
Agrawal, R., Pal, V. K., S, S. K., Menon, G. J., Singh, I. R., Malhotra, N., S, N. C., Ganesh, K., Rajmani, R. S., Seshasayee, A. S. N., Chandra, N., Joshi, M. B., Singh, A.
10.1101/2024.12.29.630646 — Posted: 2024-12-30

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).